Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Off-Label Communication Growth: Could FDA Afford To Police It?

Nov 11 2016

• By Derrick Gingery

Related Content

FDA's Off-Label Communication Changes Should Start With Payers – PhRMA

Sep 20 2016

FDA Budget Request Is Flat For Drugs, Pressuring Stakeholders

Feb 15 2016

Congressional ‘Cures’ Debate Shifts To FDA Funding

Apr 30 2015

Off-Label Communications: Industry, FDA Debate Role Of Peer Review

Nov 10 2016

‘Who Is The Arbiter?’ US FDA Asks As It Mulls Loosening Off-Label Reins

Nov 10 2016

DTC User Fees Shot Down; Advertisers Face More Perilous Future

Jan 01 2008

Sponsors, FDA Reviewers To Get More Flexibility Under New User Fee Program

Jul 16 2016

Additional Topics

United States Advertising, Marketing & Sales FDA Regulation BioPharmaceutical

More from Marketing & Advertising

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window